The Effect of Anti‐Scl‐70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis

OBJECTIVE: The objective of this study was to assess the predictive significance of anti‐Scl‐70 (anti‐topoisomerase I) antibodies, as determined by three different methods, for decline in forced vital capacity (FVC) within the first year of follow‐up in patients with systemic sclerosis (SSc)‐related...

Descripción completa

Detalles Bibliográficos
Autores principales: Jandali, Bochra, Salazar, Gloria A., Hudson, Marie, Fritzler, Marvin J., Lyons, Marka A., Estrada‐Y‐Martin, Rosa M., Charles, Julio, Terracina, Katherine A., Mayes, Maureen D., Assassi, Shervin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992461/
https://www.ncbi.nlm.nih.gov/pubmed/35048554
http://dx.doi.org/10.1002/acr2.11398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992461/
https://www.ncbi.nlm.nih.gov/pubmed/35048554
http://dx.doi.org/10.1002/acr2.11398

Ejemplares similares